Top Story

BLOG: Health care providers need to consider options offered by patient financing programs

July 1, 2015

Most health care practices have financial policies in place that require payment by cash, check or major credit card for out-of-pocket costs. However, in today’s economic environment, patients appreciate and have come to expect additional options from health care providers in the management of the cost of care. The addition of a patient financing program to a practice’s financial policy can help to ease these cost concerns.

Choosing the right patient financing program and adding it to a financial policy can be an effective way to help increase treatment acceptance, reduce time in accounts receivable and improve cash flow. Here are important considerations to use in the evaluation of patient financing programs.

Meeting News Coverage

Rivaroxaban shows continued safety data in nonvalvular AF, consistent with phase III trials

July 1, 2015
Data from an ongoing study evaluating the safety of rivaroxaban in patients with nonvalvular atrial fibrillation showed rates of major bleeding and fatalities similar to…
Meeting News Coverage

Genetic variant reduces coronary events, increases diabetes risk in familial hypercholesterolemia

June 30, 2015
CHICAGO — A PCSK9 loss-of-function genetic variant was associated with a cardioprotective effect, but increased prevalence of diabetes and prediabetes in patients…
Medicare fraud takedown: A closer look Health Care Legislative and Regulatory Update

Medicare fraud takedown: A closer look

June 30, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
In the Journals

Current monitoring of ICDs, pacemakers may underestimate device malfunction

June 30, 2015
The current monitoring of patients with cardiac implantable electronic devices may underestimate device malfunctions, leading researchers to propose new systematic…
More News Headlines »
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

VIDEO: Knowledge of supplements and drug interactions essential for HF practitioners

June 28, 2015
NEW ORLEANS – Joseph Ho, PharmD, clinical pharmacist with Ochsner Baptist Medical Center in New Orleans…
More »
CME
Antiplatelet Agents in ACS Distinguishing Characteristics Safety and Efficacy

Antiplatelet Agents in ACS: Distinguishing Characteristics, Safety, and Efficacy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
morganatic-roan